Literature DB >> 27162284

Genome-wide association study of periweaning failure-to-thrive syndrome (PFTS) in pigs.

R Zanella1, N Morés1, M A Z Morés1, J O Peixoto1, E L Zanella2, J R Ciacci-Zanella1, A M G Ibelli1, D Gava1, M E Cantão1, M C Ledur1.   

Abstract

Porcine periweaning-failure-to-thrive syndrome (PFTS) is a condition that affects newly weaned piglets. It is characterised by a progressive debilitation leading to death, in the absence of infectious, nutritional, management or environmental factors. In this study, we present the first report of PFTS in South America and the results of a genome-wide association study to identify the genetic markers associated with the appearance of this condition in a crossbred swine population. Four chromosomal regions were associated with PFTS predisposition, one located on SSCX, one on SSC8, and the two other regions on SSC14. Regions on SSC8 and SSC14 harbour important functional candidate genes involved in human depression and might have an important role in PFTS. Our findings contribute to the increasing knowledge about this syndrome, which has been investigated since 2007, and to the identification of the aetiology of this disease. British Veterinary Association.

Entities:  

Keywords:  Depression; GWAS; SNP; Sus scrofa

Mesh:

Year:  2016        PMID: 27162284     DOI: 10.1136/vr.103546

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  2 in total

1.  Unusual histopathologic features in thymic corpuscles associated with porcine periweaning failure-to-thrive syndrome.

Authors:  Francisco J Pallarés; Serafín Gómez
Journal:  J Vet Diagn Invest       Date:  2019-04-22       Impact factor: 1.279

2.  Dynamics of the Enteric Virome in a Swine Herd Affected by Non-PCV2/PRRSV Postweaning Wasting Syndrome.

Authors:  Alba Folgueiras-González; Robin van den Braak; Martin Deijs; Wikke Kuller; Steven Sietsma; Valentijn Thuring; Lia van der Hoek; Ad de Groof
Journal:  Viruses       Date:  2021-12-17       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.